Lumiera Health (TSXV:NHP.H) EV-to-EBIT : -1.94 (As of May. 23, 2024)

Lumiera Health EV-to-EBIT Chart

Lumiera Health Annual Data
	Trend	Dec13	Dec14	Dec15	Dec16	Dec17	Nov18	Nov19	Nov20	Nov21	Nov22
EV-to-EBIT		Get a 7-Day Free Trial					-8.66	-5.73	-2.52	7.76	-1.38

Lumiera Health Quarterly Data
	Sep18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23
EV-to-EBIT	Get a 7-Day Free Trial															-6.06	-1.38	-1.28	-1.55	-1.66

Competitive Comparison of Lumiera Health's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Lumiera Health's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lumiera Health's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lumiera Health's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Lumiera Health's EV-to-EBIT falls into.

Lumiera Health EV-to-EBIT Calculation

Lumiera Health's EV-to-EBIT for today is calculated as:

Lumiera Health's current Enterprise Value is C$2.52 Mil.
Lumiera Health's EBIT for the trailing twelve months (TTM) ended in Aug. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-1.30 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lumiera Health  (TSXV:NHP.H) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Lumiera Health's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Aug. 2023 is calculated as:

Lumiera Health's Enterprise Value for the quarter that ended in Aug. 2023 was C$2.16 Mil.
Lumiera Health's EBIT for the trailing twelve months (TTM) ended in Aug. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-1.30 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lumiera Health EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Lumiera Health's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Lumiera Health (TSXV:NHP.H) Business Description